APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab -paclitaxel plus gemcitabine ( nab -P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma
Tempero, Margaret A., Reni, Michele, Riess, Hanno, Pelzer, Uwe, O'Reilly, Eileen Mary, Winter, Jordan Michael, Oh, Do-Youn, Li, Chung-Pin, Tortora, Giampaolo, Chang, Heung-Moon, Lopez, Charles D., Tabernero, Josep, Van Cutsem, Eric, Philip, Philip Agop, Goldstein, David, Berlin, Jordan, Ferrara, Stefano, Li, Mingyu, Lu, Brian D., Biankin, Andrew
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Growth and Muscle Defects in Mice Lacking Adult Myosin Heavy Chain Genes
Leslie J. R. Acakpo-Satchivi, Edelmann, Winfried, Sartorius, Carol, Lu, Brian D., Wahr, Philip A., Watkins, Simon C., Metzger, Joseph M., Leinwand, Leslie, Kucherlapati, Raju
Published in The Journal of cell biology (01.12.1997)
Published in The Journal of cell biology (01.12.1997)
Get full text
Journal Article
A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer
Lin, Edward H., Lenz, Heinz‐Josef, Saleh, Mansoor N., Mackenzie, Mary J., Knost, James A., Pathiraja, Kumudu, Langdon, Ronald B., Yao, Siu‐Long, Lu, Brian D.
Published in Cancer medicine (Malden, MA) (01.08.2014)
Published in Cancer medicine (Malden, MA) (01.08.2014)
Get full text
Journal Article
Spatial and Temporal Changes in Myosin Heavy Chain Gene Expression in Skeletal Muscle Development
Lu, Brian D., Allen, David L., Leinwand, Leslie A., Lyons, Gary E.
Published in Developmental biology (01.12.1999)
Published in Developmental biology (01.12.1999)
Get full text
Journal Article
Reduction in primary pancreatic and metastatic tumor burden in the phase III MPACT trial of nab -paclitaxel ( nab -P) plus gemcitabine (Gem) versus Gem alone
Kunzmann, Volker, Ramanathan, Ramesh K., Goldstein, David, Penenberg, Darryl Neil, Ferrara, Stefano, Lu, Brian D., Von Hoff, Daniel D.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
APACT: Phase III randomized trial of adjuvant treatment with nab -paclitaxel ( nab -P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC)
Tempero, Margaret A., Cardin, Dana Backlund, Goldstein, David, O'Reilly, Eileen Mary, Philip, Philip Agop, Riess, Hanno, Macarulla, Teresa, Yung, Lotus, Li, Mingyu, Lu, Brian D., Biankin, Andrew
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
A phase II study of Chinese patients (pts) treated with nab -paclitaxel ( nab -P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC)
Shen, Lin, Yu, Xianjun, Hao, Jihui, Wang, Liwei, Pan, Hongming, Han, Guohong, Xu, Jian-Ming, Zhang, Yanqiao, Yang, Shujun, Chen, Jia, Ying, Jieer, Dai, Guanghai, Li, Mingyu, Begic, Damir, Lu, Brian D., Xu, Ruihua
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Outcome of second-line treatment (2L Tx) following nab -paclitaxel ( nab -P) + gemcitabine (G) or G alone for metastatic pancreatic cancer (MPC)
Goldstein, David, Chiorean, E. Gabriela, Tabernero, Josep, El-Maraghi, Robert Hassan, Ma, Wen Wee, Reni, Michele, Harris, Marion, Whorf, Robert C., Coughlin, Susan, Li, Jack, Manax, Victoria G., Lu, Brian D., Romano, Alfredo, Von Hoff, Daniel D.
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article